-
121
Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances
Published 2025-04-01“…Liposarcoma is one of the most prevalent forms of soft tissue sarcoma, and its prognosis is highly dependent on its molecular subtypes. …”
Get full text
Article -
122
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review
Published 2025-05-01“…Clinical studies demonstrated myo-Ins efficacy, suggesting that an appropriate ratio in between myo-Ins/DCI (40:1) improves the reproductive function in PCOS women, even in absence of insulin resistance.Expert Opinion: Inositol-based treatments in PCOS are gaining momentum, demonstrating safety and efficacy greater than those obtained with other pharmacological agents. The efficacy depends not only on the modulation of insulin sensitivity but also on the direct, steroidogenic effects upon the ovaries. …”
Get full text
Article -
123
CORRECTION OF IMMUNE STATUS IN CHILDREN WITH FREQUENTLY RECURRENT INFECTIONS WITH COMPLEX PERORAL VACCINE
Published 2011-05-01“…The market of drugs proposes some new medicines which are labeled by manufacturers as immunomodulating agents. Most of them are not licensed and they have no any evidence of their efficacy. …”
Get full text
Article -
124
Uncovering the connection between tunicamycin-induced respiratory deficiency and reduced fluconazole tolerance in Candida glabrata
Published 2025-04-01“…IntroductionCandida glabrata is a prevalent opportunistic fungal pathogen in humans, and fluconazole (FLC) is one of the most commonly used antifungal agents. However, the molecular mechanisms underlying FLC tolerance in C. glabrata remain largely unexplored.ObjectiveThis study aims to identify novel mechanisms regulating FLC tolerance, with a particular focus on tunicamycin (TUN)-induced respiratory deficiency.MethodsWe employed three distinct experimental approaches to investigate the impact of TUN on FLC tolerance: (1) co-treatment with TUN and FLC, (2) exclusive exposure to TUN, and (3) induction of petite formation through alternative methods. …”
Get full text
Article -
125
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability
Published 2025-05-01“…Abstract The blood–brain barrier (BBB) represents a formidable challenge in the treatment of neurological disorders, as it restricts the passage of most therapeutic agents into the central nervous system (CNS). …”
Get full text
Article -
126
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01“…Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer?…”
Get full text
Article -
127
The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21
Published 2025-02-01“…Abstract Emerging evidence has demonstrated that long noncoding RNAs (lncRNAs) are promising targets or agents for the treatment of human cancers. Most liver-specific lncRNAs exhibit loss of expression and act as tumor suppressors in liver cancer. …”
Get full text
Article -
128
Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Published 2025-01-01“…<i>Cannabis sativa</i> contains several pharmacologically active compounds, the most prominent of which are delta-9-tetrahydrocannabinol (∆<sup>9</sup>-THC) and cannabidiol (CBD), which interact with the body’s endocannabinoid system, thereby modulating the pain response. …”
Get full text
Article -
129
Angiogenesis in Atrial Fibrillation: A Literature Review
Published 2025-06-01“…Atrial fibrillation (AF), the most prevalent clinically significant cardiac arrhythmia, is characterized by chaotic atrial electrical activity and currently affects an estimated 2.5–3.5% of the global population. …”
Get full text
Article -
130
Emerging mechanisms and implications of m6A in CVDs: potential applications of natural products
Published 2025-06-01“…N6-methyladenosine (m6A) RNA methylation is the most common, abundant, and reversible epigenetic modification of RNAs, and it directs many essential processes in RNAs post-transcriptionally. …”
Get full text
Article -
131
Sea buckthorn flavonoids and their derivatives: potential natural compounds for the treatment of diabetic cardiomyopathy
Published 2025-07-01“…Diabetic cardiomyopathy (DCM) is one of the most common complications of diabetes, characterized by high morbidity and disability rates, and can lead to heart failure. …”
Get full text
Article -
132
USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma
Published 2025-08-01“…Targeting USP7 provides mechanistic insights into regulating diverse alkylation repair pathways and offers a strategy to enhance the efficacy of combination chemotherapies, including TMZ and other alkylating agents, by modulating distinct repair mechanisms in GBM.…”
Get full text
Article -
133
Alternative splicing fine-tunes prey shift of Coccinellini lady beetles to non-target insect
Published 2025-05-01“…Conclusion These findings unraveled the functional significance of AS reprogramming in modulating acclimation of Coccinellini lady beetles to prey shift from aphids to non-target insects and provided new genetic clues for evaluating their ecological safety as biological control agents.…”
Get full text
Article -
134
Therapeutic Potentials of MiRNA for Colorectal Cancer Liver Metastasis Treatment: A Narrative Review
Published 2025-04-01“…Colorectal cancer (CRC) ranks among the most prevalent cancers worldwide and is the fourth leading cause of cancer-related deaths. …”
Get full text
Article -
135
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials
Published 2025-03-01“…Abstract Breast cancer remains the most frequently diagnosed cancer globally, exerting a profound impact on women’s health and healthcare systems. …”
Get full text
Article -
136
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
Published 2020-10-01“…Despite doubling the median survival in comparison to untreated controls, most vaccinated mice ultimately succumbed to cancer progression. …”
Get full text
Article -
137
Astrocyte heterogeneity in ischemic stroke: Molecular mechanisms and therapeutic targets
Published 2025-06-01“…Here we systematically review current advancements in astrocyte heterogeneity following ischemic stroke, elucidate the molecular mechanisms underlying their activation, and further summarize promising therapeutic agents and molecular targets capable of modulating astrocyte heterogeneity.…”
Get full text
Article -
138
Dye-based fluorescent organic nanoparticles made from polar and polarizable chromophores for bioimaging purposes: a bottom-up approach
Published 2024-04-01“…Among them luminescent metal-, semiconductor- or oxide-based “hard” nanoparticles have been the most widely used. Yet, they raise concern with respect to toxicity and degradability issues. …”
Get full text
Article -
139
Pancreatic cancer is feeling the heat
Published 2024-10-01“…Recent advances in genomic and proteomic technology advances are finally uncovering the complex inflammatory cellular and intercellular signals that require modulation and reprogramming. The goal is to ‘turn up the heat’ on PDACs with combination immunotherapies that incorporate T cell activating agents and immune modulatory agents, and successfully eradicate tumors. …”
Get full text
Article -
140
Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLD
Published 2025-04-01“…Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) represents the most prevalent chronic liver disorder globally. Due to its intricate pathogenesis and the current lack of efficacious pharmacological interventions, there is a pressing need to discover novel therapeutic targets and agents for MASLD treatment. …”
Get full text
Article